BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 25025935)

  • 1. Economic burden of amyotrophic lateral sclerosis: a Canadian study of out-of-pocket expenses.
    Gladman M; Dharamshi C; Zinman L
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Sep; 15(5-6):426-32. PubMed ID: 25025935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Socioeconomic costs of amyotrophic lateral sclerosis according to staging system.
    Oh J; An JW; Oh SI; Oh KW; Kim JA; Lee JS; Kim SH
    Amyotroph Lateral Scler Frontotemporal Degener; 2015 Jun; 16(3-4):202-8. PubMed ID: 25646865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financial cost of amyotrophic lateral sclerosis: a case study.
    Obermann M; Lyon M
    Amyotroph Lateral Scler Frontotemporal Degener; 2015 Mar; 16(1-2):54-7. PubMed ID: 25245119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Social economic costs and health-related quality of life in patients with amyotrophic lateral sclerosis in Spain.
    López-Bastida J; Perestelo-Pérez L; Montón-Alvarez F; Serrano-Aguilar P; Alfonso-Sanchez JL
    Amyotroph Lateral Scler; 2009 Aug; 10(4):237-43. PubMed ID: 18821088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the economic burden of ALS in Greece: a cost-of-illness approach.
    Athanasakis K; Kyriopoulos II; Sideris M; Rentzos M; Evdokimidis J; Kyriopoulos J
    Amyotroph Lateral Scler Frontotemporal Degener; 2015 Mar; 16(1-2):63-4. PubMed ID: 25019279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The economic impact of amyotrophic lateral sclerosis: a systematic review.
    Gladman M; Zinman L
    Expert Rev Pharmacoecon Outcomes Res; 2015 Jun; 15(3):439-50. PubMed ID: 25924979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic cost of home-telemonitoring care for BiPAP-assisted ALS individuals.
    Lopes de Almeida JP; Pinto A; Pinto S; Ohana B; de Carvalho M
    Amyotroph Lateral Scler; 2012 Oct; 13(6):533-7. PubMed ID: 22873565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care.
    Kuenzig ME; Lee L; El-Matary W; Weizman AV; Benchimol EI; Kaplan GG; Nguyen GC; Bernstein CN; Bitton A; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S34-S41. PubMed ID: 31294383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Socioeconomic burden of psoriatic arthritis in Hong Kong: direct and indirect costs and the influence of disease pattern.
    Zhu TY; Tam LS; Leung YY; Kwok LW; Wong KC; Yu T; Kun EW; Li EK
    J Rheumatol; 2010 Jun; 37(6):1214-20. PubMed ID: 20360186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health and social care costs of managing amyotrophic lateral sclerosis (ALS): an Irish perspective.
    Connolly S; Heslin C; Mays I; Corr B; Normand C; Hardiman O
    Amyotroph Lateral Scler Frontotemporal Degener; 2015 Mar; 16(1-2):58-62. PubMed ID: 25285902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Out-of-pocket costs in the year after early breast cancer among Canadian women and spouses.
    Lauzier S; Lévesque P; Mondor M; Drolet M; Coyle D; Brisson J; Mâsse B; Provencher L; Robidoux A; Maunsell E
    J Natl Cancer Inst; 2013 Feb; 105(4):280-92. PubMed ID: 23349250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Out-of-pocket expenses incurred by patients obtaining free breast cancer care in Haiti: A pilot study.
    O'Neill KM; Mandigo M; Pyda J; Nazaire Y; Greenberg SL; Gillies R; Damuse R
    Surgery; 2015 Sep; 158(3):747-55. PubMed ID: 26150200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs and quality of life of patients with ankylosing spondylitis in Canada.
    Kobelt G; Andlin-Sobocki P; Maksymowych WP
    J Rheumatol; 2006 Feb; 33(2):289-95. PubMed ID: 16465660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mixed method approach to describe the out-of-pocket expenses incurred by families of children with cancer.
    Tsimicalis A; Stevens B; Ungar WJ; McKeever P; Greenberg M; Agha M; Guerriere D; Naqvi A; Barr R
    Pediatr Blood Cancer; 2013 Mar; 60(3):438-45. PubMed ID: 23015413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The costs of amyotrophic lateral sclerosis, according to type of care.
    van der Steen I; van den Berg JP; Buskens E; Lindeman E; van den Berg LH
    Amyotroph Lateral Scler; 2009 Feb; 10(1):27-34. PubMed ID: 18608087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost burden associated with advanced non-small cell lung cancer in Europe and influence of disease stage.
    Wood R; Taylor-Stokes G
    BMC Cancer; 2019 Mar; 19(1):214. PubMed ID: 30849964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic burden, work, and school productivity in individuals with tuberous sclerosis and their families.
    Skalicky AM; Rentz AM; Liu Z; Said Q; Nakagawa JA; Frost MD; Wheless JW; Dunn DW
    J Med Econ; 2018 Oct; 21(10):953-959. PubMed ID: 29890870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality, health, social and economic consequences of amyotrophic lateral sclerosis: a controlled national study.
    Jennum P; Ibsen R; Pedersen SW; Kjellberg J
    J Neurol; 2013 Mar; 260(3):785-93. PubMed ID: 23104122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic burden of family caregiving for elderly population in southern Ghana: the case of a peri-urban district.
    Nortey ST; Aryeetey GC; Aikins M; Amendah D; Nonvignon J
    Int J Equity Health; 2017 Jan; 16(1):16. PubMed ID: 28088236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimorbidity is associated with higher out-of-pocket spending: a study of older Australians with multiple chronic conditions.
    McRae I; Yen L; Jeon YH; Herath PM; Essue B
    Aust J Prim Health; 2013; 19(2):144-9. PubMed ID: 22950881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.